Description
PT-141: The Melanocortin Agonist Peptide for Sexual Health and Arousal Research
Ignite explorations into neuroendocrinology and sexual dysfunction with PT-141, also known as Bremelanotide, a synthetic heptapeptide derived from Melanotan II that targets central melanocortin pathways for enhanced libido and arousal. FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women since 2019, PT-141 has expanded in 2025 research to both genders, offering a non-vascular alternative to PDE5 inhibitors by acting directly on the brain’s reward and motivation centers. Our lyophilized powder in a sterile vial is primed for subcutaneous protocols, facilitating studies on erectile function, orgasmic response, and dopamine-mediated pleasure.
Mechanism of Action
PT-141 binds selectively to melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors in the hypothalamus and medial preoptic area, stimulating pro-opiomelanocortin neurons to release alpha-MSH and trigger downstream dopamine surges. This central activation promotes sexual motivation and autonomic arousal, including nitric oxide-mediated vasodilation for genital blood flow, without relying on peripheral hormone fluctuations or visual/psychological stimuli.
Key Research Benefits
-Enhanced Libido and Desire: Increases satisfying sexual events by 25-50% in HSDD models, with sustained improvements over 52 weeks in long-term studies.
– Improved Erectile and Arousal Response: Induces dose-dependent erections in men (up to 80% success rate) and genital sensitivity in women, outperforming placebos in clinical trials.
– Orgasm and Satisfaction Boost: Elevates orgasm intensity and overall sexual fulfillment, particularly in low-desire cohorts, via dopamine pathway modulation.
– Broad Applicability Across Genders: Effective for male hypoactive desire and female arousal disorders, supporting inclusive research on psychosexual health.
Dosage Considerations for Research
In experimental paradigms, PT-141 is reconstituted with bacteriostatic water and injected subcutaneously (0.5-2mg per dose, 45-60 minutes pre-activity) no more than once daily and 8 times monthly to mitigate tolerance. Titrate from 0.25mg/kg body weight; cycles of 4-8 weeks with monitoring for hyperpigmentation. Store lyophilized at 2-8°C and reconstituted solutions refrigerated for up to 30 days.
**Important Disclaimer**: PT-141 is strictly for research purposes only. Not FDA-approved for all indications; consult regulatory guidelines and institutional protocols before use. As of 2025, ongoing trials refine its off-label applications.
Why 3L Peptides?
-
Independently lab-certified for purity and potency
-
99.44% consistent peptide quality
-
Trusted by researchers worldwide
⚠️ For research purposes only.
Reconstitution: 2ml BAC water per 10mg vial → Calculate Here
Dose: 1-2mg as needed (subQ)
Cycle: Max 8x per month
Benefits: Libido enhancement, arousal, sexual performance
Notes: Use 1-2 hours before intimacy, may cause mild nausea.
- Always titrate GLP-1s slowly to avoid nausea
- Use peptidedeals.co/calculator for precise reconstitution
- Store reconstituted peptides refrigerated for up to 30 days
- Rotate injection sites to prevent lipodystrophy
- Get comprehensive blood work before and during cycles
- Bioregulators follow strict 30-day protocols, 2x yearly maximum
🔬 Legal Disclaimer: For research and educational purposes only. These compounds are not FDA-approved for human use. Always consult qualified healthcare providers and conduct thorough due diligence before use.
